Ovid Therapeutics: Single Dose Pharmacokinetics (PK) Study
Ovid Therapeutics A Phase 1 Single Dose PK Study in Adolescent Subjects With Fragile X Syndrome or Angelman Syndrome The trial is a Phase 1 Single Dose PK [...]
Ovid Therapeutics A Phase 1 Single Dose PK Study in Adolescent Subjects With Fragile X Syndrome or Angelman Syndrome The trial is a Phase 1 Single Dose PK [...]
On March 23, the Fragile X Resource Center of Missouri hosted a business meeting for all members of the group. Roughly 20 individuals enjoyed dinner, followed by the business of the group. Events since the last meeting were reviewed, along with upcoming events and opportunities. We enjoyed catching up with other following the conclusion of our business.